BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Iranzo I, Huguet JM, Suárez P, Ferrer-Barceló L, Iranzo V, Sempere J. Endoscopic evaluation of immunotherapy-induced gastrointestinal toxicity. World J Gastrointest Endosc 2018; 10(12): 392-399 [PMID: 30631403 DOI: 10.4253/wjge.v10.i12.392]
URL: https://www.wjgnet.com/1007-9327/full/v10/i12/392.htm
Number Citing Articles
1
Masakuni Fujii, Toshiki Ozato, Sho Mizukawa, Junichiro Nasu, Haruyuki Kawai, Shin-ichi Fujioka, Masao Yoshioka, Junji Shiode, Kazuhide Yamamoto. A rare case of immunotherapy-induced cholangitis and gastritisClinical Journal of Gastroenterology 2020; 13(6): 1083 doi: 10.1007/s12328-020-01218-0
2
Roie Tzadok, Sharon Levy, Jessie Aouizerate, Oren Shibolet, Marcel Cerqueira Cesar Machado. Acute Liver Failure following a Single Dose of Atezolizumab, as Assessed for Causality Using the Updated RUCAMCase Reports in Gastrointestinal Medicine 2022; 2022: 1 doi: 10.1155/2022/5090200
3
Patricia Sanz-Segura, Paula García-Cámara, Eva Fernández-Bonilla, José Miguel Arbonés-Mainar, Vanesa Bernal Monterde. Efectos adversos inmunomediados gastrointestinales y hepáticos inducidos por los inhibidores del punto de control inmunitario: estudio descriptivo observacionalGastroenterología y Hepatología 2021; 44(4): 261 doi: 10.1016/j.gastrohep.2020.07.009
4
Asunción Ojeda Gómez, Maria Isabel Pamies Ramón, Alicia Brotons Brotons, Nuria Jiménez García, Maria Dolores Picó Sala, María Cabezas Macian, Javier Sola Vera Sánchez, Mariana Fe García Sepulcre. Nivolumab-induced acute neutrophilic gastritis: Case report in a tertiary hospitalGastroenterología y Hepatología 2024; 47(1): 74 doi: 10.1016/j.gastrohep.2023.01.006
5
Kanika Sehgal, Sahil Khanna. Gut microbiome and checkpoint inhibitor colitisIntestinal Research 2021; 19(4): 360 doi: 10.5217/ir.2020.00116
6
O. Gómez Escudero. Enterocolitis and other immunotherapy and targeted therapy-related gastrointestinal manifestations: A review for gastroenterologistRevista de Gastroenterología de México (English Edition) 2024;  doi: 10.1016/j.rgmxen.2023.11.001
7
Shinsuke Otagiri, Takehiko Katsurada, Kana Yamanashi, Kensuke Sakurai, Michiko T Sato, Jun Sakakibara‐Konishi, Naoya Sakamoto. Immune checkpoint inhibitor‐induced enteritis assessed using capsule endoscopyJGH Open 2020; 4(6): 1231 doi: 10.1002/jgh3.12392
8
Ning Yang, Dexian Kong, Xv Wang, Yabin Liu. Perianal rhabdomyosarcoma in an adult: A case report and review of the literatureMedicine 2023; 102(48): e36276 doi: 10.1097/MD.0000000000036276
9
Pingxin Zhang, Ren Mao, Chuhan Zhang, Yun Qiu, Minhu Chen. Gastrointestinal injury induced by immunomodulators: A review articleTherapeutic Advances in Gastroenterology 2023; 16: 175628482311585 doi: 10.1177/17562848231158549
10
Octavio Gómez-Escudero. Benign Anorectal Disorders - An Update2023;  doi: 10.5772/intechopen.103734
11
O. Gómez-Escudero, J.M. Remes-Troche. Approach to the adult patient with chronic diarrhea: A literature reviewRevista de Gastroenterología de México (English Edition) 2021; 86(4): 387 doi: 10.1016/j.rgmxen.2021.08.007
12
Yuya Sugiyama, Hiroki Tanabe, Taisuke Matsuya, Yu Kobayashi, Yuki Murakami, Takahiro Sasaki, Takehito Kunogi, Keitaro Takahashi, Katsuyoshi Ando, Nobuhiro Ueno, Shin Kashima, Kentaro Moriichi, Mishie Tanino, Yusuke Mizukami, Mikihiro Fujiya, Toshikatsu Okumura. Severe immune checkpoint inhibitor-associated gastritis: A case series and literature reviewEndoscopy International Open 2022; 10(07): E982 doi: 10.1055/a-1839-4303
13
Patricia Sanz-Segura, Paula García-Cámara, Eva Fernández-Bonilla, José Miguel Arbonés-Mainar, Vanesa Bernal Monterde. Gastrointestinal and liver immune-related adverse effects induced by immune checkpoint inhibitors: A descriptive observational studyGastroenterología y Hepatología (English Edition) 2021; 44(4): 261 doi: 10.1016/j.gastre.2020.07.007
14
Asunción Ojeda Gómez, Nuria Jiménez García, Jorge Barragán Martínez, Andrea García Soria, Julia Sáez Fuster, María Cabezas Macián, Mariana Fe García Sepulcre. Acute neutrophilic gastritis induced by nivolumab used as a treatment of non- metastatic malignant melanomaRevista Española de Enfermedades Digestivas 2021;  doi: 10.17235/reed.2021.8295/2021
15
Albert Alhatem, Krishan Patel, Brenda Eriksen, Sarosh Bukhari, Chen Liu. Nivolumab-Induced Concomitant Severe Upper and Lower Gastrointestinal Immune-Related Adverse EffectsACG Case Reports Journal 2019; 6(11): e00249 doi: 10.14309/crj.0000000000000249
16
O. Gómez-Escudero, J.M. Remes-Troche. Abordaje de la diarrea crónica en el adulto: Revisión de la literaturaRevista de Gastroenterología de México 2021; 86(4): 387 doi: 10.1016/j.rgmx.2021.02.002
17
Atefe Pooyan, Bahar Mansoori, Carolyn Wang. Imaging of abdominopelvic oncologic emergenciesAbdominal Radiology 2023; 49(3): 823 doi: 10.1007/s00261-023-04112-8
18
O. Gómez-Escudero. Enterocolitis y otras manifestaciones de toxicidad gastrointestinal asociada a inmunoterapia y terapia blanco: una revisión para el gastroenterólogoRevista de Gastroenterología de México 2024; 89(1): 89 doi: 10.1016/j.rgmx.2023.11.001
19
Asunción Ojeda Gómez, Maria Isabel Pamies Ramón, Alicia Brotons Brotons, Nuria Jiménez García, Maria Dolores Picó Sala, María Cabezas Macian, Javier Sola Vera Sánchez, Mariana Fe García Sepulcre. Nivolumab-induced acute neutrophilic gastritis: Case report in a tertiary hospitalGastroenterología y Hepatología (English Edition) 2024; 47(1): 74 doi: 10.1016/j.gastre.2023.01.012